Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Horizon Surgical Systems is developing Polaris, an AI-enabled robotic platform designed to enhance precision and outcomes in eye surgeries such as cataract procedures. The company has raised $30M Series A funding to advance the technology toward first-in-human clinical studies. Early results are preclinical; no published human data yet[2][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Horizon Surgical Systems.